Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
Go back to Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.80 -0.22 (3.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.02 | 52 Week High | $44.38 | |||
| Open | $6.98 | 52 Week Low | $24.47 | |||
| Day High | $7.05 | P/E | 340.00 | |||
| Day Low | $6.77 | EPS | $0.02 | |||
| Volume | 1,874,482 | |||||
